_id

690db60bccc777a4e85d0dff

Ticker

BCTX

Name

Briacell Therapeutics Corp

Exchange

NASDAQ

Address

Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://briacell.com

Description

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate theclinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.

Last Close

9.54

Volume

52254

Current Price

8.975

Change

-5.922431865828087

Last Updated

2025-11-28T12:46:40.806Z

Image

data:image/webp;base64,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

Ipo Date

2021-02-24T00:00:00.000Z

Market Cap

19430114

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-0.007749999999999979

Sentiment Sources

4

Rating

4.5

Target Price

150

Strong Buy

1

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-07-31

Revenue

-

Cost Of Revenue

36427

Gross Profit

-36427

Operating Expenses

11653405

Operating Income

-11689833

Interest Expense

-

Pretax Income

-11156653

Net Income

-11057253

Eps

-5.869323097861571

Dividends Per Share

-

Shares Outstanding

1883906

Income Tax Expense

-

EBITDA

-11120230

Operating Margin

-

Total Other Income Expense Net

533180

Cash

10471593

Short Term Investments

7356866

Receivables

563598

Inventories

-

Total Current Assets

19884393

Property Plant Equipment

296190

Total Assets

21603876

Payables

3276751

Short Term Debt

-

Long Term Debt

-

Total Liabilities

4306524

Equity

17842989

Depreciation

36427

Change In Working Capital

572507

Cash From Operations

-11203995

Capital Expenditures

3.09

Cash From Investing

-10250520

Cash From Financing

18683085

Net Change In Cash

-2756262

PE

-

PB

1.00725630890654

ROE

-61.96973500347952

ROA

-51.18180182111766

FCF

-11203998.09

Fcf Percent

-

Piotroski FScore

0

Health Score

42

Deep Value Investing Score

6

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

3.5

Net Net Investing Score

4.5

Quality Investing Score

3

Value Investing Score

6.5

Quarters > 0 > quarter

2025-07-31

Quarters > 0 > income Statement > revenue

-

Quarters > 0 > income Statement > cost Of Revenue

36427

Quarters > 0 > income Statement > gross Profit

-36427

Quarters > 0 > income Statement > operating Expenses

11653405

Quarters > 0 > income Statement > operating Income

-11689833

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-11156653

Quarters > 0 > income Statement > net Income

-11057253

Quarters > 0 > income Statement > eps

-5.869323097861571

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

1883906

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-11120230

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

533180

Quarters > 0 > balance Sheet > cash

10471593

Quarters > 0 > balance Sheet > short Term Investments

7356866

Quarters > 0 > balance Sheet > receivables

563598

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

19884393

Quarters > 0 > balance Sheet > property Plant Equipment

296190

Quarters > 0 > balance Sheet > total Assets

21603876

Quarters > 0 > balance Sheet > payables

3276751

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

4306524

Quarters > 0 > balance Sheet > equity

17842989

Quarters > 0 > cash Flow > net Income

-11057253

Quarters > 0 > cash Flow > depreciation

36427

Quarters > 0 > cash Flow > change In Working Capital

572507

Quarters > 0 > cash Flow > cash From Operations

-11203995

Quarters > 0 > cash Flow > capital Expenditures

3.09

Quarters > 0 > cash Flow > cash From Investing

-10250520

Quarters > 0 > cash Flow > cash From Financing

18683085

Quarters > 0 > cash Flow > net Change In Cash

-2756262

Quarters > 0 > ratios > PE

-5.869323097861571

Quarters > 0 > ratios > PB

1.00725630890654

Quarters > 0 > ratios > ROE

-61.96973500347952

Quarters > 0 > ratios > ROA

-51.18180182111766

Quarters > 0 > ratios > FCF

-11203998.09

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

42

Quarters > 1 > quarter

2025-04-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

37922

Quarters > 1 > income Statement > gross Profit

-37922

Quarters > 1 > income Statement > operating Expenses

8965125

Quarters > 1 > income Statement > operating Income

-9003047

Quarters > 1 > income Statement > interest Expense

52608

Quarters > 1 > income Statement > pretax Income

-8856047

Quarters > 1 > income Statement > net Income

-8716587

Quarters > 1 > income Statement > eps

-4.666871725351999

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

1867758

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-8765515

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

146998.1

Quarters > 1 > balance Sheet > cash

17215085

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

3212144

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

20427229

Quarters > 1 > balance Sheet > property Plant Equipment

441639

Quarters > 1 > balance Sheet > total Assets

23489684

Quarters > 1 > balance Sheet > payables

4530548

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

6991787

Quarters > 1 > balance Sheet > equity

17152855

Quarters > 1 > cash Flow > net Income

-8716587

Quarters > 1 > cash Flow > depreciation

37922

Quarters > 1 > cash Flow > change In Working Capital

-1514203.2

Quarters > 1 > cash Flow > cash From Operations

-10105059

Quarters > 1 > cash Flow > capital Expenditures

4.04

Quarters > 1 > cash Flow > cash From Investing

-147901

Quarters > 1 > cash Flow > cash From Financing

20703914

Quarters > 1 > cash Flow > net Change In Cash

10329055

Quarters > 1 > ratios > PE

-4.666871725351999

Quarters > 1 > ratios > PB

1.0388014893147526

Quarters > 1 > ratios > ROE

-50.81712053182983

Quarters > 1 > ratios > ROA

-37.108149262459214

Quarters > 1 > ratios > FCF

-10105063.04

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

42

Quarters > 2 > quarter

2025-01-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

38398

Quarters > 2 > income Statement > gross Profit

-38398

Quarters > 2 > income Statement > operating Expenses

10289138

Quarters > 2 > income Statement > operating Income

-10327537

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-9129601

Quarters > 2 > income Statement > net Income

-9062751

Quarters > 2 > income Statement > eps

-3.3571140694467183

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

2699566

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-9091197.2

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

1197935

Quarters > 2 > balance Sheet > cash

7389123

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

3167076

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

10556200

Quarters > 2 > balance Sheet > property Plant Equipment

504772

Quarters > 2 > balance Sheet > total Assets

13800025

Quarters > 2 > balance Sheet > payables

7373773

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

9044233

Quarters > 2 > balance Sheet > equity

5309986

Quarters > 2 > cash Flow > net Income

-9062751

Quarters > 2 > cash Flow > depreciation

38398

Quarters > 2 > cash Flow > change In Working Capital

1170894

Quarters > 2 > cash Flow > cash From Operations

-8551373

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-107972

Quarters > 2 > cash Flow > cash From Financing

7695162

Quarters > 2 > cash Flow > net Change In Cash

-1173887.6

Quarters > 2 > ratios > PE

-3.3571140694467183

Quarters > 2 > ratios > PB

4.850080516219816

Quarters > 2 > ratios > ROE

-170.6737268233852

Quarters > 2 > ratios > ROA

-65.6719897246563

Quarters > 2 > ratios > FCF

-8551373

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

28

Quarters > 3 > quarter

2024-10-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

36350

Quarters > 3 > income Statement > gross Profit

-36350

Quarters > 3 > income Statement > operating Expenses

6990462

Quarters > 3 > income Statement > operating Income

-7026814

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-7949267

Quarters > 3 > income Statement > net Income

-7912310

Quarters > 3 > income Statement > eps

-4.454956423427243

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

1776069

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-7912913

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

-922451

Quarters > 3 > balance Sheet > cash

8062832

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

3378147

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

11440980

Quarters > 3 > balance Sheet > property Plant Equipment

508547

Quarters > 3 > balance Sheet > total Assets

14496747

Quarters > 3 > balance Sheet > payables

5893683

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

9328230

Quarters > 3 > balance Sheet > equity

5627352.1

Quarters > 3 > cash Flow > net Income

-7912310

Quarters > 3 > cash Flow > depreciation

36350

Quarters > 3 > cash Flow > change In Working Capital

-2874072

Quarters > 3 > cash Flow > cash From Operations

-9484499

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-102275

Quarters > 3 > cash Flow > cash From Financing

16309958

Quarters > 3 > cash Flow > net Change In Cash

6862462

Quarters > 3 > ratios > PE

-4.454956423427243

Quarters > 3 > ratios > PB

3.010953990243475

Quarters > 3 > ratios > ROE

-140.60449496309286

Quarters > 3 > ratios > ROA

-54.579899890644434

Quarters > 3 > ratios > FCF

-9484499

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

27

Valuation > metrics > PE

-5.869323097861571

Valuation > metrics > PB

1.00725630890654

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-61.96973500347952

Profitability > metrics > ROA

-55.60769695107113

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.2413566471402297

Risk > metrics > Interest Coverage

-320.9464624001318

Risk > final Score

-1224

Risk > verdict

High

Liquidity > metrics > Current Ratio

6.068325911855982

Liquidity > metrics > Quick Ratio

6.068325911855982

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

31.499194837801834

Prev Valuations > 2

49.89046009756525

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

15

Prev Risks > 0

-625

Prev Risks > 1

-1046

Prev Risks > 2

-743

Prev Liquidities > 0

100

Prev Liquidities > 1

86

Prev Liquidities > 2

99

Updated At

2025-12-16T12:14:00.119Z